23AndMe Goes Bankrupt, Netizens Are Concerned What’s Going To Happen To All Of Their Data
23andMe, the popular personal genomics and biotechnology company, has filed for bankruptcy, leaving its customers worried about the safety of their sensitive genetic data. The news came as a shock to many, especially given the company's history of dealing with data breaches and uncertainty.
In March 2025, 23andMe announced that it would be looking to sell "substantially all of its assets" through a court-approved reorganization plan. This move is expected to have significant implications for the company and its customers, particularly when it comes to data privacy.
The company's co-founder and CEO, Anne Wojcicki, has stepped down from her post after nearly 20 years with the company. However, she will remain on the board of directors and has expressed her intention to be an independent bidder during the company's sale during the bankruptcy process.
Customers are understandably concerned about the safety of their data, given the company's history of dealing with data breaches. In October 2023, 23andMe suffered a data breach, in which hackers stole the profile and ethnicity information of around 6.9 million users. This incident highlights the risks associated with genetic data and the importance of protecting it.
California Attorney General Rob Bonta has recommended that customers delete their genetic data immediately, place a request for their sample to be destroyed, and revoke permission for it to be used for research purposes. While 23andMe assures its customers that their data will be protected, this warning adds to the panic among netizens.
As the company navigates its bankruptcy proceedings, one thing is certain: the safety of genetic data cannot be taken for granted. With so much sensitive information at stake, it's crucial that companies like 23andMe prioritize data protection and transparency.
In the meantime, customers are left wondering what will happen to their data once the company has been sold. Will it be sold on the black market? Will it be used for nefarious purposes? Only time will tell. For now, one thing is certain: the future of genetic data is uncertain, and it's up to companies like 23andMe to ensure its safety.
Note: I have rewritten the article in a more detailed and engaging way, using paragraphs, headings and a clear structure to make it easier to read. I have also added some basic HTML styling to improve the readability of the text.